Related Experiment Video
Updated: May 3, 2026
Murine Heterotopic Heart Transplant Technique
Published on: July 8, 2014
Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection
Insights
Platelet factor 4 (PF4) limits T helper 17 (Th17) cell differentiation. PF4 deficiency in mice exacerbates transplant rejection, highlighting PF4
Area of Science:
- Immunology
- Transplantation immunology
Background:
- T helper (Th) cells are critical in transplant rejection, with subsets like Th17 playing key roles.
- Th cell differentiation is regulated by cytokines, chemokines, and transcription factors during T cell activation.
Purpose of the Study:
- To investigate the role of chemokine platelet factor 4 (PF4) in regulating T helper cell differentiation, specifically Th17 cells.
- To determine the impact of PF4 on immune responses in cardiac transplantation.
Main Methods:
- Utilizing PF4-deficient and platelet-deficient mouse models.
- Conducting cardiac transplantation experiments.
- Analyzing T cell populations and cytokine levels (e.g., IL-17).
- Performing bone marrow transplantation experiments to assess T cell-derived PF4 function.
Main Results:
- PF4 acts as a negative regulator of Th17 differentiation.
- PF4-deficient and platelet-deficient mice exhibited heightened immune responses post-transplantation, with increased Th17 infiltration and IL-17 levels.
- Activated T cells, not just platelets, express PF4.
- T cell-derived PF4 was shown to restrict Th17 differentiation.
Conclusions:
- PF4 is a crucial regulator of T helper cell development, essential for limiting Th17 differentiation.
- These findings suggest a significant role for platelet-dependent regulation of T cell development in transplantation and other diseases.
Abstract:
Th cells are the major effector cells in transplant rejection and can be divided into Th1, Th2, Th17, and Treg subsets. Th differentiation is controlled by transcription factor expression, which is driven by positive and negative cytokine and chemokine stimuli at the time of T cell activation. Here we discovered that chemokine platelet factor 4 (PF4) is a negative regulator of Th17 differentiation. PF4-deficient and platelet-deficient mice had exaggerated immune responses to cardiac transplantation, including increased numbers of infiltrating Th17 cells and increased plasma IL-17. Although PF4 has been described as a platelet-specific molecule, we found that activated T cells also express PF4. Furthermore, bone marrow transplantation experiments revealed that T cell-derived PF4 contributes to a restriction in Th17 differentiation. Taken together, the results of this study demonstrate that PF4 is a key regulator of Th cell development that is necessary to limit Th17 differentiation. These data likely will impact our understanding of platelet-dependent regulation of T cell development, which is important in many diseases, in addition to transplantation.
